These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11754493)

  • 1. Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors.
    Shilling PD; Feifel D
    Synapse; 2002 Feb; 43(2):134-8. PubMed ID: 11754493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats.
    Shilling PD; Feifel D; Kelsoe JR
    Neurosci Lett; 2000 Mar; 281(1):17-20. PubMed ID: 10686405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain differences in myenteric neuron number and CCK1 receptor mRNA expression may account for differences in CCK induced c-Fos activation.
    Gulley S; Sharma SK; Mansour M; Sullivan CN; Moran TH; Sayegh AI
    Brain Res; 2005 Oct; 1058(1-2):109-19. PubMed ID: 16169531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FosB in rat striatum: normal regional distribution and enhanced expression after 6-month haloperidol administration.
    Rodríguez JJ; Garcia DR; Nakabeppu Y; Pickel VM
    Synapse; 2001 Feb; 39(2):122-32. PubMed ID: 11180499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin (CCK)-8 on hypothalamic oxytocin-secreting neurons in rats lacking CCK-A receptor.
    Hashimoto H; Onaka T; Kawasaki M; Chen L; Mera T; Soya A; Saito T; Fujihara H; Sei H; Morita Y; Ueta Y
    Auton Neurosci; 2005 Aug; 121(1-2):16-25. PubMed ID: 15979947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Startle and sensorimotor gating in rats lacking CCK-A receptors.
    Feifel D; Priebe K; Shilling PD
    Neuropsychopharmacology; 2001 Jun; 24(6):663-70. PubMed ID: 11331146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
    Werme M; Ringholm A; Olson L; Brené S
    Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced CCK-induced Fos expression in the hindbrain, nodose ganglia, and enteric neurons of rats lacking CCK-1 receptors.
    Covasa M; Ritter RC
    Brain Res; 2005 Jul; 1051(1-2):155-63. PubMed ID: 16005445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic regeneration after ethionine-induced acute pancreatitis in rats lacking pancreatic CCK-A receptor gene expression.
    Sato T; Niikawa J; Usui I; Imamura T; Yoshida H; Tanaka S; Mitamura K
    J Gastroenterol; 2003; 38(7):672-80. PubMed ID: 12898360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.
    Maheux J; Ethier I; Rouillard C; Lévesque D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
    Lee J; Rushlow WJ; Rajakumar N
    Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats.
    Peitl B; Döbrönte R; Drimba L; Sári R; Varga A; Németh J; Pázmány T; Szilvássy Z
    Eur J Pharmacol; 2010 Oct; 644(1-3):251-6. PubMed ID: 20624386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats).
    Funakoshi A; Miyasaka K; Jimi A; Kawanai T; Takata Y; Kono A
    Biochem Biophys Res Commun; 1994 Mar; 199(2):482-8. PubMed ID: 8135789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors.
    Gulley S; Sharma SK; Moran TH; Sayegh AI
    Peptides; 2005 Sep; 26(9):1617-22. PubMed ID: 16112401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
    Ma J; Ye N; Cohen BM
    Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the metabolic effects of chronic clozapine treatment on CCK-1 receptor deficient Otsuka Long Evans Tokushima Fatty (OLETF) rats.
    Hegedűs C; Kovács D; Drimba L; Sári R; Varga A; Németh J; Szilvássy Z; Peitl B
    Eur J Pharmacol; 2013 Oct; 718(1-3):188-96. PubMed ID: 24036255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats.
    Grimm JW; Chapman MA; Zahm DS; See RE
    Synapse; 2001 Jan; 39(1):51-7. PubMed ID: 11071709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects.
    Moran TH; Bi S
    Dev Psychobiol; 2006 Jul; 48(5):360-7. PubMed ID: 16770763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
    Harrison MB; Kumar S; Hubbard CA; Trugman JM
    Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.